Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | ER8735 | UN / UN |
Age: 64 y.o. Admit date: 2/14/2025 Discharge date: 2/16/2025 Attending Physician at the Time of Discharge: DO Primary Care Physician: MD Reason for Admission: shock Brief Summary of Hospital Stay: 64 y.o. male with dilated cardiomyopathy (EF 25-30%) presented to ED with viral syndrome and hypotension. Admitted with viral/hypovolemic shock related to flu/covid. Hypovolemia from diarrhea and poor intake combined with recent medication increase likely contributing. Placed on IV fluid support with resolution of hypotension and Acute kidney injury. He will resume metoprolol alone (decreased dose) and follow with Cardiology to re-initiate CHF treatment. Problem list: Septic/hypovolemic shock, resolved Influenza/covid -tamiflu -tessalon, guaifenesin-dextromethorphan Dilated Cardiomoypathy (EF 25-30%) without clinical heart failure -resume toprol at decreased dose -hold Entresto, spironolactone, Jardiance -follow with Cardiology as above, may not need diuretics with no history of overload Chronic LBBB, history of NSVT -toprol resumed Acute kidney injury, resolved Right renal lesion on ultrasound -CT recommended by Radiology, follow with PCP, discussed Although leaving today, this patient will require ongoing assessment and treatment, with adjustments to the plan as appropriate. Medicine is complicated and unforseen changes in status may occur. Discharged to Home.